# A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older

> **NCT05027308** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 3 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Teduglutide

## Key facts

- **NCT ID:** NCT05027308
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2023-09-27
- **Final completion:** 2023-09-27
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027308, "A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05027308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*